Childhood cancers: open trials in Greece

31 open trials have a site in Greece. Registry data; only the trial team decides who can take part.

NCT05862285
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
Trial Treatment · Phase 3 · Hoffmann-La Roche
General Hospital "G.Papanikolaou", Asvestochóri · Metropolitan General Hospital, Cholargós
Registry updated 2026-11-06
NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Trial Treatment · Phase 2/3 · Celgene
Evaggelismos Hospital, Athens · University General Hospital Attikon, Athens · General University Hospital Of Patras, Patras
Registry updated 2026-11-02
NCT07888322
Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
Research · Aristotle University Of Thessaloniki
Department of Urology, University Hospital of Patras, Pátrai · Laboratory of Medical Physics and Digital Innovation, School of Medicine, Thessaloniki
Registry updated 2026-11-02
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Nosokomeio Paidon I Agia Sofia, Athens
Registry updated 2026-10-30
NCT07570173
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Evangelismos S A, Athens · Laiko General Hospital of Athens, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Ioannina, Ioannina
Registry updated 2026-10-30
NCT05476939
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Athens General Children's Hospital Panagioti And Aglaia Kyriakou, Athens · Nosokomeio Paidon I Agia Sofia, Athens · Mitera S.A., Marousi
Registry updated 2026-10-21
NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Trial Treatment · Phase 3 · Syndax Pharmaceuticals
University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General University Hospital of Larissa, Larissa · General University Hospital Of Patras, Patras
Registry updated 2026-10-21
2022-501180-40-00
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
Trial Treatment · Phase 3 · GPOH gGmbH
Nosokomeio Paidon I Agia Sofia, Athens · Athens General Children's Hospital Panagioti And Aglaia Kyriakou, Athens · University General Hospital of Heraklion, Heraklion · Mitera S.A., Marousi · Ippokratio General Hospital of Thessaloniki, Thessaloniki · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Registry updated 2026-10-19
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Athens General Children's Hospital Panagioti And Aglaia Kyriakou, Athens · Nosokomeio Paidon I Agia Sofia, Athens · University General Hospital of Heraklion, Heraklion · Mitera S.A., Marousi · University General Hospital of Thessaloniki - AHEPA, Thessaloniki · Ippokratio General Hospital of Thessaloniki, Thessaloniki
Registry updated 2026-10-19
NCT06941272
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Nosokomeio Paidon I Agia Sofia, Athens
Registry updated 2026-10-06
NCT06904235
Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
Trial Treatment · Phase 2 · Helsinn Healthcare SA
Aghia Sophia Children's Hospital, Pediatric Hematology/ Oncology Unit (POHemU), Athens · "AHEPA" University General Hospital of Thessaloniki, 2nd Department of Pediatrics, Thessaloniki
Registry updated 2026-09-29
NCT06423573
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
Research · Chiesi Farmaceutici S.p.A.
Hospital of Skin and Venereal Diseases of Thessaloniki, Thessaloniki
Registry updated 2026-09-28
NCT04925479
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Athens
Registry updated 2026-09-25
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Trial Treatment · Phase 2 · Pfizer
Aghia Sophia' Children's Hospital, Athens
Registry updated 2026-09-24
2023-508926-91-00
SIOP RANDOMET 2017
Trial Treatment · Phase 3 · GPOH gGmbH
Athens General Children's Hospital Panagioti And Aglaia Kyriakou, Athens · Nosokomeio Paidon I Agia Sofia, Athens · University General Hospital of Heraklion, Heraklion · Mitera S.A., Marousi · Ippokratio General Hospital of Thessaloniki, Thessaloniki · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Registry updated 2026-09-07
NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung
Saint Sophia Children's Hospital BMT Unit, Athens
Registry updated 2026-09-04
2025-522138-29-00
Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
Trial Treatment · Phase 2 · Novartis Pharma AG
Nosokomeio Paidon I Agia Sofia, Athens
Registry updated 2026-08-31
NCT06264180
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Trial Treatment · Phase 3 · Replimune, Inc.
Laiko General Hospital of Athens, Athens · General Hospital Of Thessaloniki Papageorgiou, Efkarpia
Registry updated 2026-07-15
NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Evaggelismos Hospital, Athens · Laiko General Hospital of Athens, Athens · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki
Registry updated 2026-07-06
NCT02834884
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Research · European Organisation for Research and Treatment of Cancer - EORTC
NIMTS - Veterans Administration Hospital, Athens · Athens University - Attikon University General Hospital, Athens · HYGEIA Hospital, Athens · Ioannina University Hospital, Ioannina
Registry updated 2026-06-24
NCT07642362
Digital Support for Multiple Myeloma Quality of Life
Trial Treatment · CareAcross
Alexandra General Hospital, Athens
Registry updated 2026-06-11
NCT02265770
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
Trial Treatment · Phase 2/3 · Centre Leon Berard
Nosokomeio Paidon I Agia Sofia, Athens · Athens General Children's Hospital Panagioti And Aglaia Kyriakou, Athens · University General Hospital of Heraklion, Heraklion · Mitera S.A., Marousi · Ippokratio General Hospital of Thessaloniki, Thessaloniki · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Registry updated 2026-06-10
NCT07328087
COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer
Trial Treatment · Early phase 1 · Biogenea Pharmaceuticals Ltd.
Biogenea Pharmaeuticals Ltd, Thessaloniki
Registry updated 2026-01-09
NCT07316361
GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer
Trial Treatment · Early phase 1 · Biogenea Pharmaceuticals Ltd.
Biogenea Pharmaceuticals Ltd & Interbalkan Medical Center - International Oncology Center, Thessaloniki
Registry updated 2026-01-07
NCT07285434
Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer
Trial Treatment · Early phase 1 · Biogenea Pharmaceuticals Ltd.
Biogenea Pharmaceuticals Ltd, Thessaloniki
Registry updated 2025-12-16

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error